Clinical Trial Detail

NCT ID NCT03809000
Title A Trial to See What the Results Are for Radiation Therapy and Hormone Therapy vs Radiation Therapy With Enhanced Hormone Therapy With Enzalutamide for Patients With PSA Recurrence After Surgery (STEEL)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors RTOG Foundation, Inc.
Indications

prostate adenocarcinoma

Therapies

Goserelin

Bicalutamide

Enzalutamide

Leuprolide

Age Groups: adult senior

No variant requirements are available.